KAS
VKTX icon

Kestra Advisory Services’s Viking Therapeutics VKTX Stock Holding History

Kestra Advisory Services’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Sell
27,091
-31
-0.1% -$1K ﹤0.01% 1785
2026
Q1 		$883K Buy
27,122
+2,731
+11% +$87.8K ﹤0.01% 1824
2025
Q4 		$858K Sell
24,391
-4,105
-14% -$145K ﹤0.01% 1763
2025
Q3 		$749K Buy
28,496
+1,291
+5% +$38.5K ﹤0.01% 1788
2025
Q2 		$721K Sell
27,205
-1,983
-7% -$52.2K ﹤0.01% 1707
2025
Q1 		$705K Buy
29,188
+11,050
+61% +$349K ﹤0.01% 1600
2024
Q4 		$730K Sell
18,138
-5,185
-22% -$296K ﹤0.01% 1610
2024
Q3 		$1.48M Buy
23,323
+6,982
+43% +$410K 0.01% 1116
2024
Q2 		$866K Buy
16,341
+2,146
+15% +$141K ﹤0.01% 1412
2024
Q1 		$1.16M Buy
+14,195
New +$632K 0.01% 1153
2023
Q4 		– Sell
-10,825
Closed -$120K – 2340
2023
Q3 		$120K Sell
10,825
-7,666
-41% -$110K ﹤0.01% 2000
2023
Q2 		$300K Buy
+18,491
New +$387K ﹤0.01% 1625
2021
Q1 		– Sell
-11,800
Closed -$69K – 2072
2020
Q4 		$69K Sell
11,800
-900
-7% -$5.45K ﹤0.01% 1806
2020
Q3 		$74K Buy
+12,700
New +$87.4K ﹤0.01% 1372

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Kestra Advisory Services's VKTX Position: Q2 2026 in Review

Kestra Advisory Services reduced its Viking Therapeutics (VKTX) stake by 0.11% in Q2 2026, selling an estimated $1K and leaving 27,091 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #1785.

Kestra Advisory Services first reported a position in VKTX in Q3 2020 and has held it in 14 quarters since. The position peaked at $1.48M in Q3 2024. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Kestra Advisory Services held 27,091 shares of Viking Therapeutics worth $1.06M as of Q2 2026.
  • Kestra Advisory Services sold 31 Viking Therapeutics shares in Q2 2026, an estimated $1K.
  • Viking Therapeutics made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #1785 holding.
  • Kestra Advisory Services first reported a position in Viking Therapeutics in Q3 2020 and has held it in 14 quarters since.
  • Kestra Advisory Services's Viking Therapeutics position peaked at $1.48M in Q3 2024.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.